Cargando…

Molecular Biology in Glioblastoma Multiforme Treatment

Detalles Bibliográficos
Autores principales:	Abbruzzese, Claudia, Persico, Michele, Matteoni, Silvia, Paggi, Marco G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180087/ https://www.ncbi.nlm.nih.gov/pubmed/35681545 http://dx.doi.org/10.3390/cells11111850

Ejemplares similares

Repurposing chlorpromazine in the treatment of glioblastoma multiforme: analysis of literature and forthcoming steps
por: Abbruzzese, Claudia, et al.
Publicado: (2020)

Drug repurposing for the treatment of glioblastoma multiforme
por: Abbruzzese, Claudia, et al.
Publicado: (2017)

Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma
por: Persico, Michele, et al.
Publicado: (2022)

The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells
por: Matteoni, Silvia, et al.
Publicado: (2019)

Chlorpromazine induces cytotoxic autophagy in glioblastoma cells via endoplasmic reticulum stress and unfolded protein response
por: Matteoni, Silvia, et al.
Publicado: (2021)

Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation In Vitro
por: Matteoni, Silvia, et al.
Publicado: (2021)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme
por: Abbruzzese, Claudia, et al.
Publicado: (2017)

Current and Future Novel Treatments for Glioblastoma Multiforme
por: Tyler, Betty, et al.
Publicado: (2014)

Editorial: Molecular biology of biomarkers in diagnosis and treatment of glioblastoma multiforme
por: Zhao, Jianyi, et al.
Publicado: (2023)

SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells
por: Talarico, Cristina, et al.
Publicado: (2016)

Neurocytological Advances in the Treatment of Glioblastoma Multiforme
por: Fiani, Brian, et al.
Publicado: (2021)

Systems Biology Approaches to Decipher the Underlying Molecular Mechanisms of Glioblastoma Multiforme
por: Kaynar, Ali, et al.
Publicado: (2021)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

Glioblastoma multiforme: A bigger challenge in resource-limited countries
por: Aung, LeLe
Publicado: (2013)

Potential improvement of survival statistics for glioblastoma multiforme (WHO IV)
por: Goldsmith, Harry S.
Publicado: (2019)

Migration-Associated Transportome and Therapeutic Potential in Glioblastoma Multiforme (GBM)
por: Vaid, Samir, et al.
Publicado: (2023)

Canadian recommendations for the treatment of glioblastoma multiforme
por: Mason, W.P., et al.
Publicado: (2007)

Emerging treatment strategies for glioblastoma multiforme
por: Carlsson, Steven K, et al.
Publicado: (2014)

Glioblastoma multiforme: Diagnosis, treatment, and invasion
por: Li, Jiawei, et al.
Publicado: (2023)

Biology of Glioblastoma Multiforme—Exploration of Mitotic Catastrophe as a Potential Treatment Modality
por: Vitovcova, Barbora, et al.
Publicado: (2020)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

Circular RNAs and glioblastoma multiforme: focus on molecular mechanisms
por: Salami, Raziyeh, et al.
Publicado: (2022)

Cellular and Molecular Comparison of Glioblastoma Multiform Cell Lines
por: Demircan, Turan, et al.
Publicado: (2021)

Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients
por: Lu, Jie, et al.
Publicado: (2016)

Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme
por: Lubanska, Dorota, et al.
Publicado: (2017)

Radiation and concomitant chemotherapy for patients with glioblastoma multiforme
por: Villà, Salvador, et al.
Publicado: (2014)

Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
por: Pearson, Joshua R. D., et al.
Publicado: (2020)

Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Prion Protein in Glioblastoma Multiforme
por: Ryskalin, Larisa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9d7kcp26uq8aks1tn7mj9tt346